Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer.

Annals of oncology : official journal of the European Society for Medical Oncology - 1 Jan 1999

Tascilar M, Caspers E, Sturm P D, Goggins M, Hruban R H, Offerhaus G J

Abstract excerpt

BACKGROUND: Unresectability at the time of presentation is the most important reason for the poor survival rate of pancreatic carcinoma. Molecular-based tests might improve the early detection of pancreatic cancer at a time when surgical resection is still an option for cure. METHODS: The literature was reviewed concerning the role of molecular-based tests applied to sources other than pancreatic tissue itself,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to DNA Repair

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p16

Share to Genes, ras

Share to Mutation

Share to Pancreatic Neoplasms

Source

Identifiers

PMID: 10436798

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer.PMID 10436798Read ↗

[An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].Semantic proximity Read ↗

Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer.Semantic proximity Read ↗

Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancerSemantic proximity Read ↗

Molecular analysis of pancreatic juice: a helpful tool to differentiate benign and malignant pancreatic tumors?Semantic proximity Read ↗

K-ras mutational status in cytohistological tissue as a molecular marker for the diagnosis of pancreatic cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product.Semantic proximity Read ↗

Detection of p53 gene mutations in the supernatant of pancreatic juice and plasma from patients with pancreatic carcinomas.Semantic proximity Read ↗

Detection of Ki-ras oncogene mutations in pancreatic diseases: helpful or irrelevant?Semantic proximity Read ↗

Detection of Ki-ras and p53 gene mutations in tissue and pancreatic juice from pancreatic adenocarcinomas.Semantic proximity Read ↗

Diagnosis of pancreatico-biliary malignancy: detection of gene mutations in plasma and stool.Semantic proximity Read ↗

How useful is it clinically to analyse the K-ras mutational status for the diagnosis of exocrine pancreatic cancer? A systematic review and meta-analysis.Semantic proximity Read ↗

Diagnostic value of K-ras mutations in serum of pancreatic cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.